FORM 8-K

Company

PharmaCyte Biotech, Inc.

Filed

June 28, 2012

Period of Report

May 26, 2011

Accession Number

0001262463-12-000242

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →